2 active not recruiting, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Circulating Tumor Cell: new trials by email Literature Review of Circulating Tumor Cell trials Research Report on Circulating Tumor Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery Neoadjuvant chemotherapy instead of upfront surgery, Upfront surgery - Pancreatic Cancer, Circulating Tumor Cell | Phase 2 | Active not recruiting | Elisabethinen Hospital | 100 | 2024-01-11 | 2026-11-03 |
| Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III FOLFOXIRI, CAPOX - Colorectal Neoplasms Malignant, Minimal Residual Disease | Phase 2 | Active not recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 45 | 2022-01-01 | 2026-09-15 |
| Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC Cetuximab - Lung Cancer, Surgery | Phase 2 | Withdrawn | The Netherlands Cancer Institute | 2022-01-01 | 2023-10-19 | |
| Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer Pertuzumab, Trastuzumab, Circulating tumor cells - Breast Neoplasms, HER2-positive Breast Cancer | Phase 2 | Recruiting | AC Camargo Cancer Center | 80 | 2021-03-01 | 2021-08-06 |
| Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) Cabazitaxel, Antihistamine, Corticosteroid - Circulating Tumor Cell, Metastatic Prostate Cancer | Phase 2 | Unknown | Erasmus Medical Center | 140 | 2017-02-21 | 2021-08-20 |
Neoplastic Cells, Circulating (5) · Breast Neoplasms (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Colonic Neoplasms (1) · Lung Neoplasms (1) · Neoplasm, Residual (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
Neoplasm Metastasis (5) · Neoplasms (5) · Neoplasms by Site (5) · Neoplastic Processes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Breast Diseases (1) · Central Nervous System Diseases (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Adrenal Cortex Hormones (1) · Antiemetics (1) · Cetuximab (1) · FOLFOXIRI protocol (1) · Histamine Antagonists (1) · Histamine H2 Antagonists (1) · Standard of Care (1) · Trastuzumab (1) · cabazitaxel (1) · pertuzumab (1)
AC Camargo Cancer Center (1) · Elisabethinen Hospital (1) · Erasmus Medical Center (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · The Netherlands Cancer Institute (1)
Netherlands (2) · Austria (1) · Brazil (1) · Spain (1)
Egbert Smit, prof (1) · Marcelle G Cesca, MD (1) · Marjolein van Egmond, prof (1) · Patrick Kirchweger, MD, PhD (1)